SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, cilt.42, sa.2, ss.178-180, 2008 (SCI-Expanded)
Mycophenolate mofetil (MMF) is considered to be a promising therapeutic agent in primary glomerulonephritis but there are no data on the use of MMF in Henoch-Schonlein nephritis (HSN). Herein we report the first adult crescentic HSN patient in whom long-term complete remission was achieved after MMF therapy.